Bioanalytical methods for therapeutic monoclonal antibodies and antibody–drug conjugates: A review of recent advances and future perspectives
1. 请及时下载文件确认是否正确, 系统将在 2026-06-22 16:32:31 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
K Todoroki, H Mizuno, E Sugiyama…
Journal of Pharmaceutical …, 2020
Elsevier
As the use and development of therapeutic monoclonal antibodies (mAbs) and antibody–drug conjugates (ADCs) increases, the need for accurate and robust bioanalytical methods is also increasing. Up to about a decade ago, bioanalysis of therapeutic mAbs was performed only by ligand-binding assay (LBA), and this was the only available method for absolute quantitation. Recent technological advances in liquid chromatography (LC)–tandem mass spectrometry (LC–MS/MS) and LC–high-resolution mass spectrometry can …
